Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
The link between a protein typically associated with Alzheimer’s disease and its impact on memory and cognition may not be as clear as once thought, according to a new study from the University of Wisconsin–Madison’s Waisman Center. The findings are revealing more information about the earliest stages of the neurodegenerative disease. The researchers — including …
A brain afflicted by severe Alzheimer's disease is a sad sight, a wreck of tangled neural connections and organic rubble as the lingering evidence of a fierce internal battle.
In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer's disease, a team of researchers led by Jeff Johnson, an associate professor at the School of Pharmacy, has discovered that increased expression of a protein called transthyretin in the brain appears to halt the progression of the disease.
